Europe Medical Cannabis Market, by Route of Administration

Growth Outlook

• The Europe Medical Cannabis Market, by Route of Administration market is on a steady long-term growth path. Segment value stands at roughly USD 5785 Mn in 2026 and is projected to reach USD 7328 Mn by 2027 — a gain of about 27% over the forecast period, translating to a CAGR in the double digits.
• What the regional split looks like (2026): Inhalation leads, holding roughly 58% of segment value — the single largest regional share. Oral is the second-largest contributor. Topical make up the remainder, in descending order.
• By 2027, Inhalation alone is expected to reach USD 4282 Mn, with Oral at USD 2016 Mn.

Market Dynamics

The demand for medical cannabis in Europe has been steadily increasing in recent years, and is expected to continue growing in the coming years. This can be attributed to the growing awareness and acceptance of cannabis as a medicinal product, as well as the increasing number of countries in the region legalizing its use for medical purposes.

One of the key factors driving the demand for medical cannabis in Europe is the diverse range of routes of administration available. These different methods of consuming cannabis allow for increased accessibility and convenience for patients with varying needs and preferences.

One of the most common routes of administration for medical cannabis in Europe is the oral route. This involves ingesting cannabis in various forms such as capsules, oils, and tinctures. This method is popular among patients as it offers a discreet and convenient way of consuming cannabis, with precise dosing options.

Another popular route of administration is through inhalation, either through smoking or vaporization. This method allows for immediate and efficient delivery of cannabinoids into the bloodstream, making it a preferred option for patients seeking fast-acting relief from symptoms such as pain or nausea. However, concerns over the potential negative effects of smoking have led to the growing popularity of vaporizers as a safer alternative.

Topical administration is also gaining traction in the European medical cannabis market. This involves applying cannabis-infused creams, lotions, and patches onto the skin, allowing for localized relief from conditions such as arthritis and muscle pain. This method is non-invasive and offers a discreet option for patients who may not want to consume cannabis internally.

Some countries in Europe also allow for the use of medical cannabis via suppositories, which involves inserting cannabis-infused products into the rectum or vagina. This route of administration is often used for conditions involving inflammation or pain in the pelvic region.

In addition to these traditional routes of administration, there is also increasing interest in alternative methods such as sublingual and rectal administration, which allow for the efficient absorption of cannabinoids without the need for inhalation or digestion.

Overall, the diverse range of routes of administration for medical cannabis in Europe is a key factor in driving demand for this market. As more countries continue to legalize its use for medical purposes, it is expected that there will be a further expansion of these options to cater to the growing demand for this therapeutic product.